Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 785 entries
Sorted by: Best Match Show Resources per page
Impacted Central Incisor with Dilacerated Root-Treat with Ease.

Journal of clinical and diagnostic research : JCDR

Singh N, Tripathi T, Rai P, Kalra S, Neha.
PMID: 27135026
J Clin Diagn Res. 2016 Mar;10(3):ZJ07-8. doi: 10.7860/JCDR/2016/17887.7508. Epub 2016 Mar 01.

No abstract available.

Cite
Singh N, Tripathi T, Rai P, et al. Impacted Central Incisor with Dilacerated Root-Treat with Ease. J Clin Diagn Res. 2016;10(3):ZJ07-8doi: 10.7860/JCDR/2016/17887.7508.
Singh, N., Tripathi, T., Rai, P., Kalra, S., & Neha. (2016). Impacted Central Incisor with Dilacerated Root-Treat with Ease. Journal of clinical and diagnostic research : JCDR, 10(3), ZJ07-8. https://doi.org/10.7860/JCDR/2016/17887.7508
Singh, Navneet, et al. "Impacted Central Incisor with Dilacerated Root-Treat with Ease." Journal of clinical and diagnostic research : JCDR vol. 10,3 (2016): ZJ07-8. doi: https://doi.org/10.7860/JCDR/2016/17887.7508
Singh N, Tripathi T, Rai P, Kalra S, Neha. Impacted Central Incisor with Dilacerated Root-Treat with Ease. J Clin Diagn Res. 2016 Mar;10(3):ZJ07-8. doi: 10.7860/JCDR/2016/17887.7508. Epub 2016 Mar 01. PMID: 27135026; PMCID: PMC4843412.
Copy Download .nbib Format: NLM
Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect.

Indian journal of endocrinology and metabolism

Kalra S, Jain A, Ved J, Unnikrishnan AG.
PMID: 27730088
Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):725-729. doi: 10.4103/2230-8210.183826.

This review discusses two distinct, yet related, mechanisms of sodium-glucose cotransporter 2 (SGLT2) inhibition: Calorie restriction mimicry (CRM) and pro-ketogenic effect, which may explain their cardiovascular benefits. We term these adaptive CRM and pro-ketogenic effects of SGLT2 inhibition, the...

Cite
Kalra S, Jain A, Ved J, et al. Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect. Indian J Endocrinol Metab. 2016;20(5):725-729doi: 10.4103/2230-8210.183826.
Kalra, S., Jain, A., Ved, J., & Unnikrishnan, A. G. (2016). Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect. Indian journal of endocrinology and metabolism, 20(5), 725-729. https://doi.org/10.4103/2230-8210.183826
Kalra, Sanjay, et al. "Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect." Indian journal of endocrinology and metabolism vol. 20,5 (2016): 725-729. doi: https://doi.org/10.4103/2230-8210.183826
Kalra S, Jain A, Ved J, Unnikrishnan AG. Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect. Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):725-729. doi: 10.4103/2230-8210.183826. PMID: 27730088; PMCID: PMC5040058.
Copy Download .nbib Format: NLM
Diabetes Care: Evolution of Philosophy.

Indian journal of endocrinology and metabolism

Kalra S, Baruah MP, Kalra B.
PMID: 28670528
Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):495-497. doi: 10.4103/ijem.IJEM_109_17.

No abstract available.

Cite
Kalra S, Baruah MP, Kalra B. Diabetes Care: Evolution of Philosophy. Indian J Endocrinol Metab. 2017;21(4):495-497doi: 10.4103/ijem.IJEM_109_17.
Kalra, S., Baruah, M. P., & Kalra, B. (2017). Diabetes Care: Evolution of Philosophy. Indian journal of endocrinology and metabolism, 21(4), 495-497. https://doi.org/10.4103/ijem.IJEM_109_17
Kalra, Sanjay, et al. "Diabetes Care: Evolution of Philosophy." Indian journal of endocrinology and metabolism vol. 21,4 (2017): 495-497. doi: https://doi.org/10.4103/ijem.IJEM_109_17
Kalra S, Baruah MP, Kalra B. Diabetes Care: Evolution of Philosophy. Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):495-497. doi: 10.4103/ijem.IJEM_109_17. PMID: 28670528; PMCID: PMC5477432.
Copy Download .nbib Format: NLM
Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective.

Indian journal of endocrinology and metabolism

Bahety P, Agarwal G, Khandelwal D, Dutta D, Kalra S, Taparia P, Singhal V.
PMID: 28670541
Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):564-569. doi: 10.4103/ijem.IJEM_123_17.

BACKGROUND AND AIMS: Globally, depression has been linked to Type-2 diabetes mellitus (T2DM). However, similar data from India are scant. This study evaluated the occurrence and predictors of depression and health-related quality of life (QOL) in patients with T2DM...

Cite
Bahety P, Agarwal G, Khandelwal D, et al. Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective. Indian J Endocrinol Metab. 2017;21(4):564-569doi: 10.4103/ijem.IJEM_123_17.
Bahety, P., Agarwal, G., Khandelwal, D., Dutta, D., Kalra, S., Taparia, P., & Singhal, V. (2017). Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective. Indian journal of endocrinology and metabolism, 21(4), 564-569. https://doi.org/10.4103/ijem.IJEM_123_17
Bahety, Prerna, et al. "Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective." Indian journal of endocrinology and metabolism vol. 21,4 (2017): 564-569. doi: https://doi.org/10.4103/ijem.IJEM_123_17
Bahety P, Agarwal G, Khandelwal D, Dutta D, Kalra S, Taparia P, Singhal V. Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective. Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):564-569. doi: 10.4103/ijem.IJEM_123_17. PMID: 28670541; PMCID: PMC5477445.
Copy Download .nbib Format: NLM
One Small Step for Empagliflozin, One Giant Leap for Diabetology.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S.
PMID: 26537704
Diabetes Ther. 2015 Dec;6(4):405-409. doi: 10.1007/s13300-015-0144-9. Epub 2015 Nov 04.

This article discusses the recently published EMPA-REG OUTCOME trial, which assessed cardiovascular outcomes with empagliflozin therapy in persons with type 2 diabetes mellitus and coexisting cardiovascular disease. The article describes the background and challenges of modern cardiovascular outcome trials,...

Cite
Kalra S. One Small Step for Empagliflozin, One Giant Leap for Diabetology. Diabetes Ther. 2015;6(4):405-409doi: 10.1007/s13300-015-0144-9.
Kalra, S. (2015). One Small Step for Empagliflozin, One Giant Leap for Diabetology. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(4), 405-409. https://doi.org/10.1007/s13300-015-0144-9
Kalra, Sanjay. "One Small Step for Empagliflozin, One Giant Leap for Diabetology." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 6,4 (2015): 405-409. doi: https://doi.org/10.1007/s13300-015-0144-9
Kalra S. One Small Step for Empagliflozin, One Giant Leap for Diabetology. Diabetes Ther. 2015 Dec;6(4):405-409. doi: 10.1007/s13300-015-0144-9. Epub 2015 Nov 04. PMID: 26537704; PMCID: PMC4674475.
Copy Download .nbib Format: NLM
Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective.

Journal of emergencies, trauma, and shock

Stawicki SP, Kalra S, Jones C, Justiniano CF, Papadimos TJ, Galwankar SC, Pappada SM, Feeney JJ, Evans DC.
PMID: 26604529
J Emerg Trauma Shock. 2015 Oct-Dec;8(4):224-31. doi: 10.4103/0974-2700.161658.

Modern medical management of comorbid conditions has resulted in escalating use of multiple medications and the emergence of the twin phenomena of multimorbidity and polypharmacy. Current understanding of how the polypharmacy in conjunction with multimorbidity influences trauma outcomes is...

Cite
Stawicki SP, Kalra S, Jones C, et al. Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective. J Emerg Trauma Shock. 2015;8(4):224-31doi: 10.4103/0974-2700.161658.
Stawicki, S. P., Kalra, S., Jones, C., Justiniano, C. F., Papadimos, T. J., Galwankar, S. C., Pappada, S. M., Feeney, J. J., & Evans, D. C. (2015). Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective. Journal of emergencies, trauma, and shock, 8(4), 224-31. https://doi.org/10.4103/0974-2700.161658
Stawicki, Stanislaw P, et al. "Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective." Journal of emergencies, trauma, and shock vol. 8,4 (2015): 224-31. doi: https://doi.org/10.4103/0974-2700.161658
Stawicki SP, Kalra S, Jones C, Justiniano CF, Papadimos TJ, Galwankar SC, Pappada SM, Feeney JJ, Evans DC. Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective. J Emerg Trauma Shock. 2015 Oct-Dec;8(4):224-31. doi: 10.4103/0974-2700.161658. PMID: 26604529; PMCID: PMC4626940.
Copy Download .nbib Format: NLM
South Asian Federation of Endocrine Societies: A beginning well begun.

Indian journal of endocrinology and metabolism

Kalra S, Sahay RK, Bajaj S.
PMID: 24381866
Indian J Endocrinol Metab. 2013 Nov;17(6):955-6. doi: 10.4103/2230-8210.122596.

No abstract available.

Cite
Kalra S, Sahay RK, Bajaj S. South Asian Federation of Endocrine Societies: A beginning well begun. Indian J Endocrinol Metab. 2013;17(6):955-6doi: 10.4103/2230-8210.122596.
Kalra, S., Sahay, R. K., & Bajaj, S. (2013). South Asian Federation of Endocrine Societies: A beginning well begun. Indian journal of endocrinology and metabolism, 17(6), 955-6. https://doi.org/10.4103/2230-8210.122596
Kalra, Sanjay, et al. "South Asian Federation of Endocrine Societies: A beginning well begun." Indian journal of endocrinology and metabolism vol. 17,6 (2013): 955-6. doi: https://doi.org/10.4103/2230-8210.122596
Kalra S, Sahay RK, Bajaj S. South Asian Federation of Endocrine Societies: A beginning well begun. Indian J Endocrinol Metab. 2013 Nov;17(6):955-6. doi: 10.4103/2230-8210.122596. PMID: 24381866; PMCID: PMC3872710.
Copy Download .nbib Format: NLM
Of statins and low-density lipoprotein cholesterol, "fats" and fiction.

Indian journal of endocrinology and metabolism

Unnikrishnan AG, Kalra S, Mithal A.
PMID: 27042406
Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):151-3. doi: 10.4103/2230-8210.176344.

No abstract available.

Cite
Unnikrishnan AG, Kalra S, Mithal A. Of statins and low-density lipoprotein cholesterol, "fats" and fiction. Indian J Endocrinol Metab. 2016;20(2):151-3doi: 10.4103/2230-8210.176344.
Unnikrishnan, A. G., Kalra, S., & Mithal, A. (2016). Of statins and low-density lipoprotein cholesterol, "fats" and fiction. Indian journal of endocrinology and metabolism, 20(2), 151-3. https://doi.org/10.4103/2230-8210.176344
Unnikrishnan, Ambika Gopalakrishnan, et al. "Of statins and low-density lipoprotein cholesterol, "fats" and fiction." Indian journal of endocrinology and metabolism vol. 20,2 (2016): 151-3. doi: https://doi.org/10.4103/2230-8210.176344
Unnikrishnan AG, Kalra S, Mithal A. Of statins and low-density lipoprotein cholesterol, "fats" and fiction. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):151-3. doi: 10.4103/2230-8210.176344. PMID: 27042406; PMCID: PMC4792011.
Copy Download .nbib Format: NLM
An acute need for awareness of insulin injection guidelines in operative and intensive care units.

Anesthesia, essays and researches

Bajwa SJ, Kalra S, Baruah MP, Bajwa SK.
PMID: 25885711
Anesth Essays Res. 2013 Jan-Apr;7(1):1-3. doi: 10.4103/0259-1162.113976.

No abstract available.

Cite
Bajwa SJ, Kalra S, Baruah MP, et al. An acute need for awareness of insulin injection guidelines in operative and intensive care units. Anesth Essays Res. 2013;7(1):1-3doi: 10.4103/0259-1162.113976.
Bajwa, S. J., Kalra, S., Baruah, M. P., & Bajwa, S. K. (2013). An acute need for awareness of insulin injection guidelines in operative and intensive care units. Anesthesia, essays and researches, 7(1), 1-3. https://doi.org/10.4103/0259-1162.113976
Bajwa, Sukhminder Jit Singh, et al. "An acute need for awareness of insulin injection guidelines in operative and intensive care units." Anesthesia, essays and researches vol. 7,1 (2013): 1-3. doi: https://doi.org/10.4103/0259-1162.113976
Bajwa SJ, Kalra S, Baruah MP, Bajwa SK. An acute need for awareness of insulin injection guidelines in operative and intensive care units. Anesth Essays Res. 2013 Jan-Apr;7(1):1-3. doi: 10.4103/0259-1162.113976. PMID: 25885711; PMCID: PMC4173491.
Copy Download .nbib Format: NLM
Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?.

Indian journal of endocrinology and metabolism

Kalra S.
PMID: 25941658
Indian J Endocrinol Metab. 2015 Apr;19:S71-3. doi: 10.4103/2230-8210.155407.

Over the past few decades, continuous progress has been made in the development of insulin therapy. Basal insulins were developed around 60 years ago. However, existing basal insulins were found to have limitations. An ideal basal insulin should have...

Cite
Kalra S. Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?. Indian J Endocrinol Metab. 2015;19:S71-3doi: 10.4103/2230-8210.155407.
Kalra, S. (2015). Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?. Indian journal of endocrinology and metabolism, 19S71-3. https://doi.org/10.4103/2230-8210.155407
Kalra, Sanjay. "Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?." Indian journal of endocrinology and metabolism vol. 19 (2015): S71-3. doi: https://doi.org/10.4103/2230-8210.155407
Kalra S. Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?. Indian J Endocrinol Metab. 2015 Apr;19:S71-3. doi: 10.4103/2230-8210.155407. PMID: 25941658; PMCID: PMC4413397.
Copy Download .nbib Format: NLM
Explaining, not just predicting, drives interest in personal genomics.

Genome medicine

Meisel SF, Carere DA, Wardle J, Kalia SS, Moreno TA, Mountain JL, Roberts JS, Green RC.
PMID: 26269719
Genome Med. 2015 Aug 01;7(1):74. doi: 10.1186/s13073-015-0188-5. eCollection 2015.

BACKGROUND: There is a widespread assumption that risk prediction is the major driver of customer interest in personal genomic testing (PGT). However, some customers may also be motivated by finding out whether their existing diseases have a genetic etiology....

Cite
Meisel SF, Carere DA, Wardle J, et al. Explaining, not just predicting, drives interest in personal genomics. Genome Med. 2015;7(1):74doi: 10.1186/s13073-015-0188-5.
Meisel, S. F., Carere, D. A., Wardle, J., Kalia, S. S., Moreno, T. A., Mountain, J. L., Roberts, J. S., Green, R. C. (2015). Explaining, not just predicting, drives interest in personal genomics. Genome medicine, 7(1), 74. https://doi.org/10.1186/s13073-015-0188-5
Meisel, Susanne F, et al. "Explaining, not just predicting, drives interest in personal genomics." Genome medicine vol. 7,1 (2015): 74. doi: https://doi.org/10.1186/s13073-015-0188-5
Meisel SF, Carere DA, Wardle J, Kalia SS, Moreno TA, Mountain JL, Roberts JS, Green RC. Explaining, not just predicting, drives interest in personal genomics. Genome Med. 2015 Aug 01;7(1):74. doi: 10.1186/s13073-015-0188-5. eCollection 2015. PMID: 26269719; PMCID: PMC4533947.
Copy Download .nbib Format: NLM
Diabetes insipidus: The other diabetes.

Indian journal of endocrinology and metabolism

Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H.
PMID: 26904464
Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273.

Diabetes insipidus (DI) is a hereditary or acquired condition which disrupts normal life of persons with the condition; disruption is due to increased thirst and passing of large volumes of urine, even at night. A systematic search of literature...

Cite
Kalra S, Zargar AH, Jain SM, et al. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016;20(1):9-21doi: 10.4103/2230-8210.172273.
Kalra, S., Zargar, A. H., Jain, S. M., Sethi, B., Chowdhury, S., Singh, A. K., Thomas, N., Unnikrishnan, A. G., Thakkar, P. B., & Malve, H. (2016). Diabetes insipidus: The other diabetes. Indian journal of endocrinology and metabolism, 20(1), 9-21. https://doi.org/10.4103/2230-8210.172273
Kalra, Sanjay, et al. "Diabetes insipidus: The other diabetes." Indian journal of endocrinology and metabolism vol. 20,1 (2016): 9-21. doi: https://doi.org/10.4103/2230-8210.172273
Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273. PMID: 26904464; PMCID: PMC4743391.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 785 entries